N-terminal midfragment of Osteocalcin (N-MID OC) antibody and antigen (Recombinant protein)
Diagnostic N-terminal midfragment of Osteocalcin (N-MID OC) antibodies (anti-N-terminal midfragment of Osteocalcin, anti-N-MID OC) and antigens (recombinant N-terminal midfragment of Osteocalcin (N-MID OC) protein) for Metabolic diseases N-MID OC detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Metabolic diseases diagnostics products collection >>
제품 정보
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-h-N-MID-OC-Ag01 | Recombinant human N-MID OC Protein | $3090.00 |
GMP-h-N-MID-OC-Ab01 | Anti-human N-MID OC mouse monoclonal antibody (mAb) | $1953.00 |
GMP-h-N-MID-OC-Ab02 | Anti-human N-MID OC mouse monoclonal antibody (mAb) | $1953.00 |
GMP-h-N-MID-OC-Ab03 | Anti-human N-MID OC human monoclonal antibody (mAb) | $1953.00 |
GMP-h-N-MID-OC-Ab04 | Anti-human N-MID OC human monoclonal antibody (mAb) | $1953.00 |
Size: 1mg | 10mg | 100mg
제품 설명
Cat No. of Pruducts | GMP-h-N-MID-OC-Ag01 |
Product Name | Recombinant human N-MID OC Protein |
Target/Biomarker | N-terminal midfragment of Osteocalcin (N-MID OC) |
Alias of Target/Biomarker | BGLAP, BGP, OC, OCN |
Expression platform | mammalian |
Isotypes | Recombinant Antigen |
Bioactivity validation | N-terminal midfragment of Osteocalcin (N-MID OC) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in N-MID OC level test of Metabolic diseases (osteoporosis) and related syndrome evaluation |
Products description | Recombinant Human N-terminal midfragment of Osteocalcin (N-MID OC) protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Pruducts | GMP-h-N-MID-OC-Ab01, GMP-h-N-MID-OC-Ab02 |
Product Name | Anti-human N-MID OC mouse monoclonal antibody (mAb) |
Target/Biomarker | N-terminal midfragment of Osteocalcin (N-MID OC) |
Alias of Target/Biomarker | BGLAP, BGP, OC, OCN |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Human N-terminal midfragment of Osteocalcin (N-MID OC) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other N-terminal midfragment of Osteocalcin (N-MID OC) antibodies in N-MID OC level test of Metabolic diseases (osteoporosis) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human N-MID OC mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other N-terminal midfragment of Osteocalcin (N-MID OC) antibodies. |
Reconized/Reactive Species | Human |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Pruducts | GMP-h-N-MID-OC-Ab03, GMP-h-N-MID-OC-Ab04 |
Product Name | Anti-human N-MID OC human monoclonal antibody (mAb) |
Target/Biomarker | N-terminal midfragment of Osteocalcin (N-MID OC) |
Alias of Target/Biomarker | BGLAP, BGP, OC, OCN |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Human N-terminal midfragment of Osteocalcin (N-MID OC) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other N-terminal midfragment of Osteocalcin (N-MID OC) antibodies in N-MID OC level test of Metabolic diseases (osteoporosis) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human N-MID OC mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Reconized/Reactive Species | Human |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
참고 문헌
검증 데이터
Click to get more Data / Case study about the product.
Target/Biomarker 정보
The procollagen type I N-terminal propeptide (P1NP) and osteocalcin (OC) are the the most sensitive markers of bone formation rate. Although labile, assay of intact osteocalcin (iOC) is established as the standard assay for evaluating osteoblastic function. Study examines the clinical usefulness of the newly developed immunoradiometric assay for osteocalcin (OC), which identifies the stable N-terminal midfragment of OC (N-MID OC assay). The findings suggest that N-MID OC immunoreactivity is much more stable than iOC immunoreactivity and that N-MID OC assay may be less susceptible to the OC fragments reported to accumulate in uremic serum. It may, therefore, prove more reliable than iOC assay for evaluating bone turnover, and thus for reflecting bone loss.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.